Anti-bacterial
- Active ingredient (INN)
- imipenem + [cilastatin]
- Composition (active ingredients)
- imipenem monohydrate - 530,0 mg (in terms of imipenem - 500.0 mg); cilastatin sodium - 532.0 mg (in terms of cilastatin - 500.0 mg)
- Фармакотерапевтическая группа
- carbapenem antibiotic + renal dehydropeptidase blocker
- Pharmacotherapeutic group
- powder for solution for infusion 500 mg + 500 mg vial. 20 ml No. 1
- Сonditions of supply
- on prescription
Indications
Indications
To prevent postoperative infections in patients at risk with a high probability of developing postoperative infectious complications, as well as in patients with a high risk of intraoperative infection during surgery. Treatment of severe infections caused by microorganisms sensitive to the drug, as well as for empirical treatment of the infectious process before determining its bacterial pathogens:- intra-abdominal infections;
- lower respiratory tract infections;
- urinary tract infections;
- infections of bones and joints;
- infections of the skin and soft tissues;
- gynecological infections;
- bacterial septicemia;
- bacterial endocarditis.
Dosage regimen
Dosage regimen
Intravenous drip. Dosage form for intravenous administration should not be administered intramuscularly. The calculation of the total daily dose of Imipenem + Cilastatin should be based on the severity of the infection and distributed among several applications in equal doses, taking into account the degree of sensitivity of one or more pathogenic microorganisms, kidney function and body weight.
Contraindications
There are contraindications, consult with a specialist before use
